Born 1978. B.S. Business Administration, University of Lincoln, U.K.
Martin Hillsten brings 20 years of experience in the medical device and life sciences industry including dental implants, imaging, cardiovascular intervention, and contrast media. He has a proven track record of success as a CEO specializing in driving international business growth, organizational development, and navigating regulatory frameworks and brings a wealth of knowledge of the American medical device market. His expertise lies in building and scaling businesses, leading high-performing teams, and establishing strong market positions in both local and global markets. He most recently served as CEO of Integration Diagnostics, a company that develops, manufactures and markets products to measure the stability of an implant and its ability to integrate with bone tissue (osseointegration) and has additionally held roles at NSK Nordic, Bracco, and Nobel Biocare.
Staff member since May 2025.
Shares in Integrum, own and party holders: B-Shares: 100,000